The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Sep. 10, 2024
Filed:
Jun. 03, 2022
Applicant:
Tenacia Biotechnology (Hong Kong) Co., Limited, Sheung Wan, HK;
Inventor:
M. Amin Khan, Evanston, IL (US);
Assignee:
Tenacia Biotechnology (Hong Kong) Co., Limited, Hong Kong, CN;
Attorneys:
Primary Examiner:
Int. Cl.
CPC ...
C07D 471/10 (2006.01); A61K 9/00 (2006.01); A61P 25/02 (2006.01); A61P 25/06 (2006.01); A61P 25/18 (2006.01); A61P 25/22 (2006.01); A61P 25/24 (2006.01); A61P 25/28 (2006.01); C07D 487/10 (2006.01);
U.S. Cl.
CPC ...
C07D 471/10 (2013.01); A61K 9/0019 (2013.01); A61P 25/02 (2018.01); A61P 25/06 (2018.01); A61P 25/18 (2018.01); A61P 25/22 (2018.01); A61P 25/24 (2018.01); A61P 25/28 (2018.01); C07D 487/10 (2013.01);
Abstract
Disclosed are compounds having potency in the modulation of NMDA receptor activity. Such compounds can be used in the treatment of conditions such as depression and related disorders. Orally delivered formulations and other pharmaceutically acceptable delivery forms of the compounds, including intravenous formulations, are also disclosed.